참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Cyanamide | HCID 9864 | — |
| 반응물 | N-bromobutanimide | HCID 67184 | — |
| 반응물 | Sodium permanganate monohydrate | HCID 516876 | — |
| 반응물 | Sodium Bisulfate | HCID 516919 | — |
| 반응물 | Potassium tert-butoxide | HCID 23665647 | — |
| 반응물 | 2-methoxy-3-(methylsulfanyl)-N-(1-methyl-1H-tetrazol-5-yl)-4-(trifluoromethyl)benzamide | HCID 89768792 | — |
| 용매 | Methanol | HCID 887 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | HCID 89768781 | HCID 89768781 | — |
| 생성물 | HCID 89768782 | HCID 89768782 | — |
반응 단계
At RT, 234 mg (5.56 mmol) of cyanamide and 1.06 g (5.96 mmol) of N-bromosuccinimide were added in succession to a solution of 1.14 g (3.27 mmol) of 2-methoxy-3-(methylsulfanyl)-N-(1-methyl-1H-tetrazol-5-yl)-4-(trifluoromethyl)benzamide and 440 mg (3.92 mmol) of potassium tert-butoxide in 70 ml of methanol. The contents were then stirred at RT for 16 h. For work-up, the mixture was freed from the solvent on a rotary evaporator at a temperature of at most 30° C. The residue was stirred in a mixture of 150 ml of ice-cold dichloromethane and 50 ml of ice-cold aqueous 10% by weight strength sodium bisulfate solution for about two minutes. After phase separation, the aqueous phase was extracted with 50 ml of dichloromethane. On a rotary evaporator, the combined organic phases were freed from the solvent. The residue was taken up in 60 ml of acetonitrile and 60 ml of water. 1.57 g (9.80 mmol) of sodium permanganate monohydrate were then added. The reaction mixture was stirred at RT for four days. For work-up, aqueous 10% by weight strength sodium bisulfate solution was added. Water was then added, and the mixture was extracted three times with dichloromethane. On a rotary evaporator, the combined organic phases were freed from the solvent at a temperature of at most 30° C. The residue was purified chromatographically, which gave 40 mg of 3-(N-cyano-S-methylsulfinimidoyl)-2-methoxy-N-(1-methyl-1H-tetrazol-5-yl)-4-(trifluoromethyl)benzamide and 650 mg of 3-(N-cyano-S-methylsulfonimidoyl)-2-methoxy-N-(1-methyl-1H-tetrazol-5-yl)-4-(trifluoromethyl)benzamide.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US09167819B2 |
|---|
| 출처 데이터셋 | uspto-grants-2015_10 |
|---|
| ORD ID | ord-57f46a2cf8b64ab2908d72254c341c93 |
|---|
| 출처 메모 | uspto-grants-2015_10 |
|---|